UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051444
Receipt number R000058677
Scientific Title The difference in efficacy of octanoic acid and decanoic acid, medium-chain fatty acids.
Date of disclosure of the study information 2023/06/27
Last modified on 2023/06/26 15:36:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

About the difference in efficacy depending on the carbon number of medium-chain fatty acids

Acronym

Effects of medium-chain fatty acid carbon number on muscle function, cognitive function, and feeding and swallowing function.

Scientific Title

The difference in efficacy of octanoic acid and decanoic acid, medium-chain fatty acids.

Scientific Title:Acronym

The difference in efficacy of octanoic acid and decanoic acid, medium-chain fatty acids.

Region

Japan


Condition

Condition

Frail elderly subjects

Classification by specialty

Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine whether the number of carbons of medium-chain fatty acids has an effect on the improvement of muscle function, cognitive function, and feeding and swallowing function in the elde.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in physical function, cognitive function, and swallowing function will be compared before and after 1.5 months of intervention. Body measurements and body composition will be estimated by body weight, body mass index (BMI), body fat percentage, body fat mass, skeletal muscle mass, upper arm circumference (AC), triceps subcutaneous fat thickness (TSF), upper arm muscle circumference (AMC), upper arm muscle area (AMA), and lower leg circumference (CC). Physical performance is estimated by grip strength, maximum walking speed, number of repetitive openings and closings of the lower extremities, quadriceps endurance, lower extremity muscle strength, respiratory muscle function (peak flow meter), and functional independence measures (FIM). Cognitive function is estimated with the Mini-Mental State Examination (MMSE) and the N Mental State Rating Scale for the Elderly (NM scale).
Eating and swallowing function is estimated with the Repeated Saliva Swallowing Test (RSST), the Revised Water Swallowing Test (MWST), and tongue pressure muscle strength.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

The first group is the "octanoate group" that takes MCT (C8:0). C8:0 Mix 6 g (54 kcal) of MCT containing about 97% with rice or miso soup and take it for lunch. The intervention will last approximately 1.5 months.

Interventions/Control_2

The second group is the "decanoic acid group" taking MCT (C10:0). C10:0 Mix 6 g (54 kcal) of MCT containing about 97% with rice or miso soup and take it for lunch. The intervention will last approximately 1.5 months.

Interventions/Control_3

The third group is the "LCT group," that takes LCT. LCT is mixed with rice or miso soup and consumed for lunch. The intervention will last approximately 1.5 months.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Elderly subjects in a nursing care home for the elderly volunteered to participate in a 3-mo dietary supplement intervention program. All residents in this nursing care home need special care by other people for living. They are classified into Japanese nursing care levels with number between 1 and 5 based on assessed care needs.

Key exclusion criteria

Those in need of enteral or intravenous nutritional therapy. Patients who have severe dysphagia and cannot take food orally. Those who have a level of consciousness rating (JCS: Japan coma scale) of 2-2 or higher. Type I diabetes mellitus and those with serious cardiac, hepatic, renal, or hematological diseases. Fasting blood glucose level of 200 mg/dl or higher. CRP 2.0 mg/dl or higher. Persons who frequently fall ill. BMI 25.0 kg/m2 or higher. Subjects with relevant food allergies. Persons who are unable to understand the study. Persons who are judged not to be included in the study by the facility director, who is the facility physician.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Sakiko
Middle name
Last name Abe

Organization

Tezukayama University

Division name

Department of Food and Nutrition, Faculty of Contemporary Human Life Science

Zip code

631-8585

Address

3-1-3 Gakuenminami, nara-shi, nara-ken, Japan

TEL

0742-41-4742

Email

sa-abe@tezukayama-u.ac.jp


Public contact

Name of contact person

1st name Sakiko
Middle name
Last name Abe

Organization

Tezukayama University

Division name

Department of Food and Nutrition, Faculty of Contemporary Human Life Science

Zip code

631-8585

Address

3-1-3 Gakuenminami, nara-shi, nara-ken, Japan

TEL

0742-41-4742

Homepage URL


Email

sa-abe@tezukayama-u.ac.jp


Sponsor or person

Institute

Tezukayama University

Institute

Department

Personal name



Funding Source

Organization

Tezukayama University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tezukayama University

Address

3-1-3 Gakuenminami, nara-shi, nara-ken, Japan

Tel

0742414742

Email

sa-abe@tezukayama-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

04-42

Org. issuing International ID_1

Tezukayama University Research Ethics Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

介護老人保健施設 大和田の里(奈良県)


Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 06 Month 01 Day

Date of IRB

2023 Year 03 Month 20 Day

Anticipated trial start date

2023 Year 06 Month 27 Day

Last follow-up date

2023 Year 10 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 06 Month 25 Day

Last modified on

2023 Year 06 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058677


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name